ストックスクリーナーアプリを入手
9.4298
0.10%
-0.6002
Artelo Biosciences Inc (ARTL) 最新ニュース
Chart based exit strategy for Artelo Biosciences Inc.Free Optimized Watchlist With Daily Adjustments - Newser
Will Artelo Biosciences Inc. rebound enough to break evenBuy and Hold Return Summary with Charts - Newser
Risk vs reward if holding onto Artelo Biosciences Inc.ROI Focused Setup With Drawdown Analysis - Newser
Artelo Biosciences secures European patent protection for cancer drug - Investing.com
European Patent Win Secures 20-Year Protection for Revolutionary Cancer Anorexia Treatment in Phase 2 Trials - Stock Titan
Technical signs of recovery in Artelo Biosciences Inc.Free Value Investing Picks With Stability - Newser
What institutional flow reveals about Artelo Biosciences Inc.Breakout Watcher with Entry and Exit Alerts - Newser
Using Bollinger Bands to evaluate Artelo Biosciences Inc.Intraday Signal Forecast for Fast Traders - Newser
Multi factor analysis applied to Artelo Biosciences Inc.Swing Trade Watchlist with Entry Zones - Newser
Does Artelo Biosciences Inc. qualify in momentum factor screeningTrading Volume Anomaly Summary and Insight - Newser
Solana News Today: Solana Climbs 4.05% as Artelo Biosciences Invests $9.475M in Treasury - AInvest
Combining price and volume data for Artelo Biosciences Inc.Forecast Model for Intraday Buy Signals - Newser
Artelo Biosciences Inc. Moves Into Bullish Territory Based on MACDEntry Alert With Low Drawdown Strategy Noted - beatles.ru
Will a bounce in Artelo Biosciences Inc. offer an exitTrade Ideas Based on Fundamental Metrics - Newser
Artelo Biosciences Partners with ABK Labs for Strategic Growth - TipRanks
Artelo Biosciences Closes $9.475 Million Private Placement to Adopt Solana as Core Reserve Asset - AInvest
Artelo Biosciences Sees 15min Chart Trigger KDJ Golden Cross, Bullish Marubozu - AInvest
Artelo Biosciences: Boral Capital maintains Buy, PT raised to $18 from $15. - AInvest
Biocardia Stock Plunges 12.76% Amid Market Volatility - AInvest
Artelo Biosciences stock soars after announcing $9.5M private placement for Solana-based treasury - Investing.com Canada
Artelo Biosciences (ARTL): D. Boral Capital Adjusts Price Target, Maintains Buy Rating | ARTL Stock News - GuruFocus
Artelo Biosciences stock rating reaffirmed at Buy by D. Boral Capital - Investing.com Nigeria
Solana News Today: Artelo Biosciences Allocates $9.475M to Build Solana Digital Asset Reserve Strategy - AInvest
Artelo Biosciences announces private placement to initiate Solana treasury - TipRanks
Artelo Biosciences shares surge after unveiling $9.5M private placement tied to Solana-based treasury plan - MSN
Solana News Today: Artelo Biosciences Adopts Solana as Treasury Asset After $9.475M Raise - AInvest
Artelo Biosciences Soars 13.73% on Clinical Trial Success, Blockchain Strategy - AInvest
Artelo Biosciences Initiates SOL Treasury Strategy with PIPE Financing, Partnering with CUBE and Bartosz Lipiński - Quiver Quantitative
Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Core Reserve Asset - The Manila Times
Artelo Biosciences raises $9.5M, adopts Solana as treasury asset By Investing.com - Investing.com Nigeria
Artelo Biosciences raises $9.5M, adopts Solana as treasury asset - Investing.com India
Artelo Biosciences raises $9.5M in PIPE, expands SOL treasury management strategy. - AInvest
Artelo Biosciences Announces $9.475 Million At-the-Market - GlobeNewswire
Artelo Biosciences Launches Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL - AInvest
Pharmaceutical Pioneer Artelo Makes History: Raises $9.5M to Build First-Ever Solana Treasury Strategy - Stock Titan
3 Numbers Investors Need to Pay Attention to When Investing in Stablecoins - The Globe and Mail
Mobileye Announces Participation in Upcoming Third Quarter 2025 Investor Conferences - The Globe and Mail
Artelo Biosciences Inc. Recovery Likely Here’s What Data ShowsBreakout Entry Signal Confirmation Tool Used - metal.it
What is the risk reward ratio of investing in Artelo Biosciences Inc. stockFree Consultation - Jammu Links News
Is it the right time to buy Artelo Biosciences Inc. stockExceptional market positioning - Jammu Links News
What are the technical indicators suggesting about Artelo Biosciences Inc.Unlock powerful trading signals and alerts - Jammu Links News
What are analysts’ price targets for Artelo Biosciences Inc. in the next 12 monthsGet daily expert analysis on top stocks - Jammu Links News
When is Artelo Biosciences Inc. stock expected to show significant growthInvest confidently with real-time updates - Jammu Links News
What catalysts could drive Artelo Biosciences Inc. stock higher in 2025Free Wealth Planning Blueprint - Jammu Links News
How strong is Artelo Biosciences Inc. company’s balance sheetGet daily updates on market movers and shakers - Jammu Links News
What drives Artelo Biosciences Inc. stock priceBuild a diversified portfolio for steady growth - Jammu Links News
What analysts say about Artelo Biosciences Inc. stockInvest confidently with professional market insights - Jammu Links News
Is Artelo Biosciences Inc. a good long term investmentExceptional trading performance - Jammu Links News
Can Artelo Biosciences Inc. recover in the next quarterIntelligent Trade Forecast With AI Analytics - newser.com
How does Artelo Biosciences Inc. compare to its industry peersDiscover top stock picks for aggressive growth - Jammu Links News
What are the latest earnings results for Artelo Biosciences Inc.Unlock real-time trading signals for gains - Jammu Links News
What is the dividend policy of Artelo Biosciences Inc. stockUnprecedented profits - Jammu Links News
Is Artelo Biosciences Inc. a growth stock or a value stockUnlock powerful trading tools for investors - Jammu Links News
Does Artelo Biosciences Inc. stock perform well during market downturnsRapid market gains - Jammu Links News
0.80%
3.01%
大文字化:
|
ボリューム (24 時間):